menu ☰
menu ˟

FDA approves Viekira Pak for treatment of HCV

19 Dec 2014
The FDA today approved a treatment for patients with hepatitis C virus genotype 1 infection, including those with cirrhosis, according to a press release.A combination of ombitasvir, paritaprevir and ritonavir tablets with dasabuvir tablets, Vieki...

Click here to view the full article which appeared in Hepatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.